IAPAC mourns the passing of Canadian HIV researcher, Mark A. Wainberg, PhD, who identified lamivudine (3TC) as effective against HIV, fought HIV denialism, advocated global scale-up of antiretroviral therapy, and promoted the right of HIV-vulnerable people to live free of social intolerance. Click here to read IAPAC’s statement.
IAPAC launches Recommendations for the Rapid Expansion of HIV Self-Testing in Fast-Track Cities
IAPAC launched Recommendations for the Rapid Expansion of HIV Self-Testing in Fast-Track Cities during a joint Brazilian National STI, HIV/AIDS & Viral Hepatitis Program – IAPAC meeting of that country’s cities held January 26, 2017, in Brasília. Developed in collaboration with ASLM, the recommendations promote interventions to break down barriers to this testing technology and promote linkage to HIV care and prevention. Click here to access the recommendations.
